- Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication
- Dow Pharmaceutical Sciences Becomes Wholly Owned Subsidiary as Acquisition by Valeant Pharmaceuticals International is Completed
- Veeda Oncology Announces $3 million in New Business for their Oncology Network
From,
http://www.pharmatutor.org/pharma-news/
